China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume

Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 288,100 shares of SXTC short. 2.44% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.44% of China SXT Pharmaceuticals' floating shares are currently sold short.

China SXT Pharmaceuticals saw a increase in short interest in August. As of August 31st, there was short interest totaling 288,100 shares, an increase of 553.3% from the previous total of 44,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

China SXT Pharmaceuticals currently has issued a total of 11,430,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 11,790,000 shares.

2.44% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to China SXT Pharmaceuticals: Histogen Inc. (0.97%), Humanigen, Inc. (3.48%), Clearmind Medicine Inc. (3.87%), Altamira Therapeutics Ltd. (0.69%), TransCode Therapeutics, Inc. (1.71%), Galmed Pharmaceuticals Ltd. (0.21%), Scopus BioPharma Inc. (0.84%), Infinity Pharmaceuticals, Inc. (2.43%), Evofem Biosciences, Inc. (22.89%), Allarity Therapeutics, Inc. (0.91%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is August, 31 2023.